64 related articles for article (PubMed ID: 26445463)
1. Bisphosphonates and risk of upper gastrointestinal cancer--a case control study using the General Practice Research Database (GPRD).
Wright E; Schofield PT; Seed P; Molokhia M
PLoS One; 2012; 7(10):e47616. PubMed ID: 23112825
[TBL] [Abstract][Full Text] [Related]
2. Obesity and the Incidence of Upper Gastrointestinal Cancers: An Ecological Approach to Examine Differences across Age and Sex.
Arnold M; Colquhoun A; Cook MB; Ferlay J; Forman D; Soerjomataram I
Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):90-7. PubMed ID: 26494763
[TBL] [Abstract][Full Text] [Related]
3. Exposure to weak opioids and risk of gastrointestinal tract cancers: A series of nested case-control studies.
Houston MG; McMenamin Ú; Johnston B; McDowell RD; Hughes CM; Murchie P; Cardwell CR
Br J Clin Pharmacol; 2023 Sep; 89(9):2757-2766. PubMed ID: 37117154
[TBL] [Abstract][Full Text] [Related]
4. Chronic atrophic gastritis and risk of incident upper gastrointestinal cancers: a systematic review and meta-analysis.
Li J; Pan J; Xiao D; Shen N; Wang R; Miao H; Pu P; Zhang H; Yv X; Xing L
J Transl Med; 2024 May; 22(1):429. PubMed ID: 38711123
[TBL] [Abstract][Full Text] [Related]
5. Bisphosphonates and risk of cancers: a systematic review and meta-analysis.
Li YY; Gao LJ; Zhang YX; Liu SJ; Cheng S; Liu YP; Jia CX
Br J Cancer; 2020 Nov; 123(10):1570-1581. PubMed ID: 32901134
[TBL] [Abstract][Full Text] [Related]
6. Histologic evaluation of femoral nerve demyelinating and axonal neuropathy in Wistar rats due to alendronate intake: a randomised study.
Theodora P; Apostolos P; Vasileios P; Sofia K; Eva-Maria D; Antonia S
J Biol Res (Thessalon); 2020 Dec; 27():2. PubMed ID: 32099834
[TBL] [Abstract][Full Text] [Related]
7. Exposure to oral bisphosphonates and risk of gastrointestinal cancer.
Choi D; Choi S; Chang J; Park SM
Osteoporos Int; 2020 Apr; 31(4):775-782. PubMed ID: 32034451
[TBL] [Abstract][Full Text] [Related]
8. Association between tooth loss and upper gastrointestinal cancer: A 30-year follow-up of the Linxian Dysplasia Nutrition Intervention Trial Cohort.
Zhang S; Yu P; Wang JB; Fan JH; Qiao YL; Taylor PR
Thorac Cancer; 2019 Apr; 10(4):966-974. PubMed ID: 30883021
[TBL] [Abstract][Full Text] [Related]
9. Oral bisphosphonates and colorectal cancer.
Vogtmann E; Corley DA; Almers LM; Cardwell CR; Murray LJ; Abnet CC
Sci Rep; 2017 Mar; 7():44177. PubMed ID: 28281559
[TBL] [Abstract][Full Text] [Related]
10. Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux.
Vaughan TL; Farrow DC; Hansten PD; Chow WH; Gammon MD; Risch HA; Stanford JL; Schoenberg JB; Mayne ST; Rotterdam H; Dubrow R; Ahsan H; West AB; Blot WJ; Fraumeni JF
Cancer Epidemiol Biomarkers Prev; 1998 Sep; 7(9):749-56. PubMed ID: 9752982
[TBL] [Abstract][Full Text] [Related]
11. Bisphosphonate use and gastrointestinal tract cancer risk: meta-analysis of observational studies.
Oh YH; Yoon C; Park SM
World J Gastroenterol; 2012 Oct; 18(40):5779-88. PubMed ID: 23155320
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of adenocarcinoma of the esophagus, gastric cardia, and upper gastric third.
Vial M; Grande L; Pera M
Recent Results Cancer Res; 2010; 182():1-17. PubMed ID: 20676867
[TBL] [Abstract][Full Text] [Related]
13. Oral Bisphosphonate Exposure and the Risk of Upper Gastrointestinal Cancers.
Vogtmann E; Corley DA; Almers LM; Cardwell CR; Murray LJ; Abnet CC
PLoS One; 2015; 10(10):e0140180. PubMed ID: 26445463
[TBL] [Abstract][Full Text] [Related]
14. Oral Bisphosphonates and Upper Gastrointestinal Cancer Risks in Asians with Osteoporosis: A Nested Case-Control Study Using National Retrospective Cohort Sample Data from Korea.
Jung SY; Sohn HS; Park EJ; Suh HS; Park JW; Kwon JW
PLoS One; 2016; 11(3):e0150531. PubMed ID: 26937968
[TBL] [Abstract][Full Text] [Related]
15. Use of anti-inflammatory drugs and lower esophageal sphincter-relaxing drugs and risk of esophageal and gastric cancers.
Fortuny J; Johnson CC; Bohlke K; Chow WH; Hart G; Kucera G; Mujumdar U; Ownby D; Wells K; Yood MU; Engel LS
Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1154-1159.e3. PubMed ID: 17644046
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
